Manufacturers Life Insurance Company, The Castle Biosciences Inc Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Castle Biosciences Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 9,920 shares of CSTL stock, worth $276,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,920
Previous 10,122
2.0%
Holding current value
$276,272
Previous $220,000
28.18%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CSTL
# of Institutions
206Shares Held
27.1MCall Options Held
278KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$84.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$51 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$50.9 Million0.26% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$40 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$35.1 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $732M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...